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The management of pulmonary tuberculosis
in the Border sub-region, 1983
R. F. INGLE, L. M. IRWIG
summary
In order to study the management of pulmonary tuberculosis
among black and coloured adults in the Border region of
South Africa in 1983, a historical inception cohort represen-
tative of tuberculosis hospitals and local authority health
services was followed up over 15 months to assess how
efficiently the national responsibility is discharged in a region.
About 75% of patients were sputum-positive, and 81% were
judged to have had active pulmonary tuberculosis. The mean
service delay after radiography was about 1~ weeks. About
26% of patients were treated with a rifampicin regimen, 50%
were frequent attenders and 41% completed treatment,
although about 21 % were still being treated after 15 months.
There was a deficiency of laboratory information for diagnosis
and monitoring of response to treatment. Periodic cohort
evaluation and improvement of diagnostic efficiency, of peri-
pheral use of laboratories, and of spending on community
service infrastructure are essential for closing the gap be-
tween policies and implementation.
S Air Med J 1991; 79: 127-133.
The diagnosis of pulmonary tuberculosis is not as straight-
forward as might be expected; and this is why there are
difficulties in delegating management to primary care ser-
vices.l-3 It is not easy, especially in rural areas, to assemble at
one place and time the clinical, bacteriological, and radio-
logical evidence, let alone the expertise, upon which sound
diagnosis is based. One of the aims of this study was to
evaluate the outcome of the diagnostic process as it had to be
practised in the Border region of the eastern Cape in 1983.
In programme evaluation inception cohon design is neces-
sary to establish true proponional outcomes, and routine
cross-sectional health service data are unsuitable for this pur-
pose.4,5 Inception cohorts should be representative of all the
people for whom the service is responsible. The fragmentation
of such a responsibility complicates the assembly of cohorts.
The study also dealt with this problem.
Nine studies of actual service programmes have, to our
knowledge, been published in South Mrica since 1980.6-14
Four reported on diagnostic status.9,lO,13,14 In 3 studies patients
were reported as confirmed8,l2 or notified7 cases of pulmon~
tuberculosis; and in 2 studies this status was not discussed.6, 1
Six of these reports studied cohorts,6,7,9,lO,12,14 and 3 sought
results representative of one authority or region.7,IO,14
Particular objectives of this study were to discover for the
study area: (I) the age-specific incidence of patients treated for
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pulmonary tuberculosis; (i/) the proportion of patients who
had active pulmonary tuberculosis and who had previously
been treated for the disease; (ii/) the amount of clinical infor-
mation appearing in clinical records; (iv) the delay after presen-
tation before starting treatment (health service delay); (v) the
drug regimens used initially; (vz) what proponions of patients
were denotified, transferred out of the study area, stopped
attending for treatment, and completed treatment; (viI) the
pattern of patients' compliance with treatment; (viiI) the pattern
of sputum-eonversion during treatment; and (ix) to compare
the compliance of initially hospitalised with initially ambulant
patients.
Populations and methods
The study area was the Border corridor between Ciskei and
Transkei, comprising the magisterial districts of East London,




Fig. 1. The Border study area.
The study population comprised black and coloured people
aged:;;" 15 years whose treatment for pulmonary tuberculosis
in the study area had been started before July 1983.
Data from the Department of Health and Welfare (Eastern
Cape) showed that about 90% of treatment in the area was
provided by four health services: the South Mrican National
Tuberculosis Association hospital at Fort Grey (SANTA), the
Infectious Diseases Hospital, East London (IDH), the East
London City Health Department (CITY) and the Divisional
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Council of Kafraria (KDC). Sampling excluded the munici-
palities of Stunerheim, King William's Town, Beacon Bay,
and Gonubie because they treated extremely few black patients.
The four general hospitals in the area were also excluded
because, although their passive case-finding role is very impor-
tant, the number of cases they continue to treat is very small.
Inception cohort
A historical inception cohon was assembled by taking subsets
of patients IDH + SANTA, CITY, and KDC. The names of
all eligible patients starting treatment in a cenain number of
complete months immediately preceding July 1983 (IS months
before data collection began) were taken from the treatment
registers of the 12 local authority clinics and the admission
registers of the 2 hospitals. The calculation of a 12-month
denominator for the study area statistics is shown in Table I.
The numerator for each statistic for the study area as a whole
is the sum of the subset statistics each re-weighted according
to the formula:
Subset statistic X 12
Period of recruitment (mo.)
Data collection
A questionnaire for abstracting the required data from
records was developed and pre-tested. All questionnaires were
completed by one of us (R.F.I.).
Radiographic review
The initial radiographs of patients who were thought to be
sputum-negative or had no sputum infonnation available at
the time treatment began, together with inactive controls, were
re-read without any clinical information by 4 experienced
radiographic readers who were asked to express, as a percentage
probability, whether appearances were due to active pulmonary
tuberculosis. 15
Calculation of compliance
The frequency of expecred anendance for treatment varied
widely in the study area. Treatment in hospital was supervised
daily; treatment in the city was supervised 5 days a week;
treatment in the rural areas was given out monthly or bi-
monthly. Compliance is here defmed as the anendances (for
either treatment or collection of treatment) expressed as a
percentage of anendances expected. It was assumed that com-
pliance in hospital and for supervised treatment at work was
100%. Calculations of overall compliance provided for changes
of regimen as follows:
Overall compliance = (Cl X PI) + (~XPJ + etc.
""1 T
Where Cl> ~,etc. = percentage compliance with first, second
and subsequent regimens; PI' P2' etc. = duration of first,
second and subsequent regimens; and T = total period of
treatment.
Patients were divided into the four categories of compliance
used by Saunders et ae (c) early drop-outs - patients who
stopped receiving treatment within three months of starting;
(it) late drop-outs - patients who stopped receiving treatment
between 3 months and 9 months of starting; (iic) infrequent
anenders - patients who anended for > 9 months but
received < 80% of expected treatment; and (iv) frequent
anenders - patients who attended for > 9 months and
received> 80% of expected treatment.
Because no uniform period of treatment penained in the
study area the last two categories were divided into those
whose treatment was completed (i.e. as a result of a medical
decision), those who stopped anending after between 10
months and IS months, and those still anending after IS
months.
Incidence of active disease
To estimate the incidence of active disease being treated,
patients· who were transferred out of the study area were
excluded on the assumption that they belonged outside the
study area. Patients who were denotifted were also excluded.
The subset numerator was then reduced by the proportion
judged to have had inactive disease, and then increased by a
factor of 1,1 for the proportion of patients treated in the study.
area who were not sampled. The population figures for the
study area in 1983 were provided by the Epidemiology Direc-
torate: Department of National Health and Population Deve-
lopment (personal communication).
Confidence limits
Ninety-five per cent confidence limits will appear in brackets.
The confidence intervals of proportions artived at using
weighting factors have been calculated using the formula:
Vw = W I 2 X PI (I-PI) + W2 2 X P 2 (I-P2) + etc.
VI NI - -w N2
where Pp P2' etc. = proponion for first, second, etc. subsets;
WI, W2, etc. = weighting factor applied to first, second, etc.
subset proponions; W = sum of weighting factors; and Vw =
variance of weighted proportion.
TABLE I. APPLICATION OF WEIGHTING FACTORS TO THE COHORT SUBSETS TO PRODUCE
A DENOMINATOR FOR THE STUDY AREA
Kind of No. of patients Recruitment Weighting Calculated annual
service in subset period' factor No. of patients
INH + SANTA 120 2 months x 6 720 (61,7%)
CITY 112 4 months x 3 336 (28,8%)
KDC 83 9 months x..! 111 (9,5%)3
----
Border study area total 1167 (100%)
• Months preceding July 1983
-
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Results
Completeness of data
The clinical records of 4 of the 315 patients (1,3%) studied
were not available but some information was available from
admission and treatment registers. Data were missing con-
cerning compliance for 20 patients (6%) and concerning
management outcome for 6 patients (2%).
Age-specific incidence of patients who began
treatment (Fig. 2)
The median age (and inter-quartile range) of patients was 38
years (13 years). Most patients (24%) were in the age group
25 - 34 years; however, the peak age-specific incidence of 1749
patients/105 study population shifted to the 55 - 64-year age
group.
Sputum status and active disease (Table H)
At the time treatment began 71% patients (66 - 76%) had
been shown to be sputum-positive and 21 % sputum-negative.
No information was available in 8%. Of the laner two groups
20% were judged on radiographic review to have a more than
60% probability of active disease (mean of 4 readers), which is
6% of all patients. After treatment began 4% more were shown
to be sputum-positive. The contrasting figures for the three
services are shown in Table H. It can be concluded that
altogether about 81 % had active pulmonary tuberculosis
(IDH + SANTA 89%, CITY 71%, KDC 59%).
Delay in treatment (Table HI)
The median interval between the first recorded encounter
with the patient and the start of treatment was 1\12 weeks. By 3
weeks 20% of patients had not begun treatment, and by 5
weeks 10% of patients had not begun treatment.
Incidence of active pulmonary tuberculosis
The incidence of active pulmonary tuberculosis being treated
among this population of 105 094 black and coloured people>
15 years of age in the study area in 1983 was calculated to be
745/105•
TABLE Ill. INTERVALS BETWEEN FIRST RECORDED
ENCOUNTER WITH PATIENT AND START OF
TREATMENT (WKS)
Clinical information
A positive source of infection for new disease was identified
or specifically excluded in about 8% of records. Physical signs
were seld,om recorded. There was no information, either posi-
tive or negative, about cough in 21%, sputum in 97%, duration
of cough in 89%, or duration of illness in 45%.




























Fig. 2. Age-specific incidence'of patients who began treatment.
Past history
A past history of treatment for pulmonary tuberculosis was
recorded in 37% of patients (31 - 43%). A negative history was
recorded in 15%. No positive or negative history was recorded
in 48%. Of patients treated before, 47% had been treated































TABLE 11. SPUTUM STATUS (%) OF PATIENTS WHEN TREATfJlENT BEGAN OR WITHIN 2 WEEKS AFTERWARDS AND
RETROSPECTIVE ESTIMATE OF PATIENTS WITH ACTIVE PULMONARY TUBERCULOSIS
a b c d e
Sputum- Sputum- No sputum Late sputum- Not sputum- Active
positive" negative" information positivet positive but pulmonary tuber-
judged active culosis
Kind of service on radiographic
review
IDH + SANTA 82 16 3 5 2 89
CITY 63 26 10 1 7 71
KDC 26 39 35 5 28 59
Border 71 21 8 4 6 81
• By direct examination.
t Direct- or culture-positive for the first time more than 2 weeks after treatment began.
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Drug regimens used (Table IV)
Eight combinations of streptomycin (S), isoniazid (H),
pyrazinamide (Z), ethambutol (E), and rifampicin (R) were in
use in the smdy area. Most IDH + SANTA and CITY
patients were treated with the SHZE regimen (62% and 59%,
respectively). Most KDC patients were treated with the three-
drug HZE regimen (67%). Only 26% of all patients (20,5 -
31,5%) received a rifampicin-eontaining regimen.
the remainder, 12% had incomplete data, had died or had their
treatment stopped for medical or disciplinary reasons; 3,5%
(1,5 - 5,5%) were early drop-outs; 10% (8 - 12%) were late
drop-outs; 24% (18 - 30%) were infrequent attenders; and the
remaining 50% (43 - 57%) were frequent attenders. Forty-one
per cent (34-48%) were actually discharged from treatment of
whom 63% were frequent attenders, 37% infrequent attenders
and 99% had been treated for more than 12 months. Twenty-
one per cent were still attending after 15 months.
"Percentage of patients
SHZE = streptomycin-INH-pyrazinamide-ethambutol; A-regimen = any regimen
























TABLE V. MAIN CATEGORIES OF OUTCOME (%)
Compliance with· treatment (Fig. 3)
This analysis excluded denotified patients (3%) and patients
transferred out of the smdy area and not followedup (19%). Of
Sputum conversion
From 1 month onwards after treatment began there was no
information about sputum in 80% of patients (SANTA 58%,
IDH 85%, CITY 89% and KDC 79%). Of the 8% of patients
about whom there was spumm information at 5 months 4%
were spumm-positive. Of the 20% of patients at SANTA




D Stopped attending 10-15 months
D Still attending after 15 months
~Treatmentcompleted
12%
Incomplete Early Late Infrequent Frequent





Fig. 3. Compliance with treatment. Patients who were denotified
or transferred out of the study area are excluded.
Compliance of those initially hospitalised and
those initially ambulant (Fig. 4)
Five per cent of the initially ambulant had incomplete data
(3%), had died (1%) or had treatment stopped (1%). Eighteen
per cent of the initially hospitalised died in hospital (10%) or
had treatment stopped for 'disciplinary' reasons (8%). Early"
drop-outs in the initially hospitalised was 2,4% (0,3 - 8,3%)
and in the initially ambulant 4,7% (1,4 - 8,0%). Frequent
attenders in the initially hospitalised was 47% (36 - 58%) and
in the initially ambulant 54% (46,5 - 61,5%).
Discussion
Age-specific incidence of pulmonary tuber-
culosis
The pattern of this estimate of the age-specific incidence of
treated pulmonary mberculosis and its peak (between 55 - 64
years) in the smdy area (Fig. 2) corresponded well with the











Denotified - not pulmonary tuberculosis
Transferred out of the study area and not
followed up
Died




for. medical or 'disciplinary' reasons
Completed treatment
Total
Main outcomes during management (Table V)
The diagnosis of pulmonary mberculosis for 3% of patients
was subsequently changed (denotified). Nineteen per cent
were transferred out of the smdy area before treatment was
complete. Four-and-a-half per cent of patients died, 3% being
attributable to pulmonary mberculosis; 16,5% were still attend-
ing for treatment after 15 months. The treatment of 1% of
patients was stopped for medical reasons, and of 3% for non-
compliance or behaviour unacceptable to the instimtion where
they were being treated ('disciplinary' reasons). Twenty per
cent stopped attending for no known reasons. Thirty-two per
cent (26,5 - 37,5%) completed treatment within the smdy area.
-
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tell in retrospect how the decision to treat was made; we can
only consider the outcome.
Seventy-five per cent of patients were sputum-positive (INH
+ SANTA 87%, CITY 64%, KDC 31%) (Table 11). Figures in
Thomson and Myrdal's'J study were 74% for hospitals, 43%
for Cape Town clinics, and 22% for clinics in Ciskei. The
figure in Fisher's9 study for 2 Cape Divisional Council clinics
was 72%.
Sputum-negativity, particularly under programme condi-
tions, does not exclude active disease. '8-20 To use 70% or 50%
probability as the criterion of activity in the radiographic
review would change the proportion of all treated patients
judged active to 4,8% or 9,4% respectively (unpublished data).
Escreet and Cowie/' in a seminal article, allot the highest
score for radiography (5), out of a diagnostic score of 10, for
cavitation in upper or lower lobe apical segments. Very few of
the radiographs reviewed showed cavitation.
However, the programme clinicians' responsibility was to
decide whether or not to treat patients, which is also a
probabilistic decision. But there is a strong tendency to simplify
medical decision-making.22 'Anyone uncomfortable dealing
with probabilities can use the heuristic: if there is any chance
of (the disease), the (procedure) should be performed.'22 Thus,
important programme parameters can depend on personalised
judgements. The final proportion of patients considered to
have active disease was 81 %. High as this proportion may
seem, its real meaning is that 1:5 patients was treated unneces-
sarily. Furthermore 16,5% of patients, irrespective of initial
sputum status, were still attending for treatment after 15
months.
The position regardin~ diagnostic criteria, summarised by
Thomson and Myrdal/ is uncertain. The Department of
Health and Welfare's 1979 Tuberculosis Policy Statement is
only one of such that is non-committal. It is not surprising
that, in the absence of agreed diagnostic criteria, operational
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Fig. 4. Comparison of compliance between initially hospitalised
(H) and initially ambulant (A) patients. Those denotified or trans-







pulmonary tuberculosis for 1983 in the eastern Cape (within
which the study area falls) received by the Epidemiology
Directorate, Department of National Health and Population
Development (personal communication).
Previously treated patients
The proportion of patients in a treatment programme who
have been treated previously, especially recently, is a rough
index of prevailing relapse rates. The Department of National
Health and Population Development reported in Epidemio-
logical Comments16 that 11% of new patients in the eastern
Cape in 1985 and 1986 had had relapses or re-infections. In
this study at least 37% of patients had been treated before,
although not necessarily in the study area. If we reduce this by
20% - the proportion of patients we have judged, in retrospect,
to be inactive and allow that half of these patients (those who
had been treated before within 2Y2 years) were treatment
relapses - then we may conclude that between 15% and 30%
of patients had reactive pulmonary tuberculosis.
Diagnostic status
The Department of National Health and Population Deve-
10pment17 found the question of how new cases were diagnosed
disquieting; radiography and bacteriology had accounted at
most for only 42%. In the study more than 99% of patients had
had radiography and 92% had had at least one sputum exami-
nation (INH + SANTA 97,5%, CITY 90%, KDC 65%). The
amount of recorded clinical information was scanty. We cannot
Treatment delay
Aoki et al. 24 found that doctors' delay always exceeded
patients' delay even when total delay exceeded 2 months. For
those who underwent radiography at their first visit median
doctors' delay was 13 days. Our estimate of median service
delay in the Border region is the same, but the median service
delay for the rural service was 4 weeks, and 10% of all patients
had not begun treatment 5 weeks after radiography (Table 11).
Since the earliest encounter recorded in most patients was the
date of radiography, we think these results are underestimates
of health service delay. Such observations should temper the
common criticism of patients' delay.
Drug regimens used
The impact of the 1979 Department of Health and Welfare
Tuberculosis Policy Statement on rifampicin deployment was
'weakened because provision was not made, for the financial
and logistic implications.25 The Department of National Health
and Population Development16 reported for the eastern Cape
for 1985 and 1986 rifampicin usage of 84% and 83%, respec-
tively. This study showed that in the Border region in 1983
less than one-third of patients received rifampicin. Supervision
was implied in the Policy Statement as a prerequisite for its
use, but this opportunity was not even exploited in hospitals,
since only 32% of patients there received rifampicin. On the
other hand, the difficulty of supervising daily or intermittent
treatment in KDC is reflected in 67% of patients being on a
3-drug regimen (HZE). Although this regimen does not appear
in the Policy Statement, Kleeberg26 reported only 3% treatment
failures and 4% relapses with it.
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Main outcomes of management
The complexities of the diagnostic process, which are both
clinical and logistic, may result in overtreatment of patients. A
management programme that is properly aware of this will use
therapeutic trials and patient reviews. We suggest that such
programme sensitivity is reflected in denotification rates. In
this study the rate was 3%.
Members of the health services in the study area at the time
emphasised the management problems created by influx and
efflux of patients from neighbouring Transkei and Ciskei.
Nineteen per cent of patients were transferred out of the
region before treatment was completed and their outcome is
not known. This compares with 23% (32 patients) at SANTA
and at a city clinic who were both born and domiciled in
Transkei or ~iskei (unpublished observations). The Depart-
ment of Nanonal Health and Population Development' did
not report such an outcome category for the eastern Cape but
reported for 1986 that 71% of black and coloured patients were
cured and discharged, whereas we found that, even after
excluding patients transferred out, the proportion completing
treatment only increased from 32% to 41%.
Compliance
About 14% of patients stopped anending before 9 months,
about 24% were infrequent anenders, and about 50% anended
frequently. Sacken and Haynes' suggest that the normal panern
for :o~pli~ce ~ith long-term medication may be U-shaped
III dlstrlbunon With, for example, one-third of patients taking
almost no medication, one-third taking almost all, and the rest
scanered in between. Indeed Rouillon,27 in a classic comment,
thought that only an abnormal person would be coldly intellec-
tual enough to swallow medicine every day. By comparison,
this study population was unusually compliant, and 21% were
still anending after 15 months! Unfortunately there is a ten-
~e~c! to treat the non-eompliant as deviants. On the contrary,
It IS Important that we think of highly compliant behaviour as
unusual and therefore needing special motivation and support.
Dropping out from treatment need not be equated with
treatment failure. _FOX28 and, .in South Africa, Zabow and
Pearson29 have drawn anention to the probabilities of cure-
with modem ultra-short course regimens and the arresting of
disease in patients who stopped anending after 40 - 80 doses.
Also, as Sacken and Haynes4 pointed out, some of those who
drop out might be subjects who did not have active disease.
Our samples were not large enough to infer this.
Sputum-conversion
With the powerful drug regimens now available, reduction
in coughing and sputum production, and sputum-eonversion
are bener indicators of response to treatment in the short-term
than radiography. The paucity of information about sputum-
conversion shows that insufficient importance was attached to
this means of assessment. In 1983 76% of patients whose sputa
were examined at the Frere Hospital regional laboratory were
in hospitals and 11% were with local authority health services.
Less than 1% were with the KDC (unpublished observations).
We think that peripheral services feel disadvantaged with
regard to laboratory services. There must be something awry if
it is found easier to perform radiography in a rural patient
than to examine the sputum.
Hospital v. clinic treatment
The Department of National Health and Population Deve-
10pIlientl6 reported that in 1985 and 1986 72% of all cases in
the eastern Cape received treatment in clinics and 28% in
hospitals as though these were separate populations. We found
(Table I) that 62% of patients began treatment in hospital and
38% of patients began treatment as outpatients. There were no
significant differences in compliance between the two groups,
although the hospital group began with an assumed 100%
compliance.
Conclusions
Our fmding that about 19% of patients were treated unneces-
sarily shows how easily the diagnostic process can be com-
promised. Operational research, which is needed to improve
the effectiveness of the Tuberculosis Control Programme,
could establish standards for diagnostic efficiency. 30.3 I
Other results of this study, which show important dif-.
ferences from the large-scale and cross-sectional data of the
Tuberculosis Control Programme, were available 8 months
after the study started. We think that local prospective cohort
evaluation is necessary and feasible.
The study showed, not for the first time, a deficiency of
laboratory information in the KDC for both diagnosis' and
monitoring of treatment response. Laboratory services are still
regarded as a perk of central services instead of a way of
strengthening otherwise disadvantaged peripheral services.
Supervised outpatient treatment using a 4-drug regimen,
and rifampicin, where possible, has been State policy since
1979. Yet in the Border in 1983 62% of patients began
treatment in hospital. The proportion of patients with active
disease was considerably higher among the initially hospitalised
than among the initially ambulant. Rifampicin was used in
only 17% of outpatient regimens because of little opportunity
to supervise treatment. An active transfer of resources to
community services' infrastructure is imperative for ambulatory
treatment to be successful. 31 Without sufficient of these
resources the Border health services appear to some extent 1:0
have achieved treatment objectives bener by hospitalising
their patients.
What is wrong with the Tuberculosis Control Programme
has become known in South Africa as 'the tuberculosis prob-
lem' and has been debated for years. The spread of operational
research, which is really a management function, is confJrmin§
gaps between policy and implementation. Francis Peabody3
said that the secret of the care of the patient is in caring for the
patient. We conclude by echoing him: thafthe secret of bener
management of tuberculosis is to manage tuberculosis bener.
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